4.5 Review

T-helper cell-mediated factors in drug-induced liver injury

Journal

JOURNAL OF APPLIED TOXICOLOGY
Volume 35, Issue 7, Pages 695-700

Publisher

WILEY
DOI: 10.1002/jat.3115

Keywords

T-helper cells; Cytokine; Drug-induced liver injury; SOCS; STAT; Notch

Categories

Funding

  1. Fundamental Research Funds for the Central Universities [ZD2014YW0032]
  2. National Natural Science Foundation of China [81173651, 81274146, 81102887, 81320108029]
  3. 111 Project [111-2-07]

Ask authors/readers for more resources

Drug-induced liver injury (DILI) leads to a large burden on the healthcare system due to its potential morbidity and mortality. The key for predicting and preventing DILI is to understand the underlying mechanisms. Hepatic inflammation is one of the most common features of DILI. The inflammation can be attributed to the innate immune response. The adaptive immune system is also affected by the innate immune response resulting in liver damage. T-helper cells are important regulators of acquired immunity. T-helper cell-mediated immune responses play pivotal roles in the pathogenesis of a variety of liver disorders. This review summarizes recent advances in the T-helper cell-mediated factors in DILI and potential mechanisms, which may lead to a better understanding of DILI. Copyright (c) 2015 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available